What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Fluoroquinolones (for systemic and inhalation use) New
PSUFU
|
08/11/2024
Further information is available on the hma-Website.
5_Fluorouracil (iv use) New
PSUR-outcome
|
08/11/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amantadine New
PSUR-outcome
|
30/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amitriptyline/Perphenazine New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
valproic acid and derivates New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amitriptyline, Amitriptyline/Amitriptylinoxide, Amitriptylinoxide New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Macrogol 3350- combinations (oral use) New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Allopurinol New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Medroxyprogesterone acetate (MPA) New
PRAC signal recommendation
|
08/10/2024
Risk for Meningioma. Further information and amendments to the product information can be found on the EMA website.